Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresis

Author： Schwartz David   Ferguson John R.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.11, 2007-11, pp. : 2715-2728

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 4, 2012-07 ,pp. : 246-252

Karger

Access to resources Recommend Favorite

Successful treatment of neutrophilic dermatosis in patient with Crohn's disease with granulocyte and monocyte adsorption apheresis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 8, 2015-08 ,pp. : 836-837

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 33, Iss. 1, 2018-02 ,pp. : 99-103

John Wiley & Sons Inc

Access to resources Recommend Favorite

Granulocyte and monocyte adsorption apheresis for paradoxical reaction to infliximab

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 4, 2015-04 ,pp. : 438-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phytochemicals and Their Potential Usefulness in Inflammatory Bowel Disease

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 3, 2015-03 ,pp. : 339-350

John Wiley & Sons Inc

Access to resources Recommend Favorite